Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2004-2489PMID 15914535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Materials become insensitive to flaws at nanoscale: Lessons from nature

  2003cited by this paper
• Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment.

  2003cited by this paper
• Effect of Hormone Replacement Therapy on Bone Quality in Early Postmenopausal Women

  2003cited by this paper
• Distribution of Collagen Cross‐Links in Normal Human Trabecular Bone

  2003cited by this paper
• Bone Mineral and Collagen Quality in Humeri of Ovariectomized Cynomolgus Monkeys Given rhPTH(1–34) for 18 Months

  2003cited by this paper
• Biomechanics of Bone: Determinants of Skeletal Fragility and Bone Quality

  2002cited by this paper
• Spectroscopic Characterization of Collagen Cross‐Links in Bone

  2001cited by this paper
• A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality.

  2001cited by this paper
• Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

  2001cited by this paper
• Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women.

  2001cited by this paper
• Intermittently Administered Human Parathyroid Hormone(1–34) Treatment Increases Intracortical Bone Turnover and Porosity Without Reducing Bone Strength in the Humerus of Ovariectomized Cynomolgus Monkeys

  2001cited by this paper
• The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys.

  2001cited by this paper
• Biomechanics of Fracture: Is Bone Mineral Density Sufficient to Assess Risk?

  2000cited by this paper
• Mineralized collagen fibrils: a mechanical model with a staggered arrangement of mineral particles.

  2000cited by this paper
• Determinants of Bone Loss from the Femoral Neck in Women of Different Ages

  2000cited by this paper
• Bone Matters: Are Density Increases Necessary to Reduce Fracture Risk?

  2000cited by this paper
• Characterizing the Performance of a Fast FT-IR Imaging Spectrometer

  1999cited by this paper
• Age-Related Changes in the Biochemical Properties of Human Cancellous Bone Collagen: Relationship to Bone Strength

  1999cited by this paper
• The role of collagen in the declining mechanical properties of aging human cortical bone.

  1999cited by this paper
• Infrared spectroscopy, microscopy, and microscopic imaging of mineralizing tissues: spectra-structure correlations from human iliac crest biopsies.

  1999cited by this paper
• Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys.

  1999cited by this paper
• Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies.

  1998cited by this paper
• Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs.

  1997cited by this paper
• FTIR Microspectroscopic Analysis of Human Iliac Crest Biopsies from Untreated Osteoporotic Bone

  1997cited by this paper
• FTIR Microspectroscopic Analysis of Normal Human Cortical and Trabecular Bone

  1997cited by this paper
• Unraveling the Role of Structure and Density in Determining Vertebral Bone Strength

  1997cited by this paper
• Pyridoxine deficiency affects biomechanical properties of chick tibial bone.

  1996cited by this paper
• Calcium and phosphorus in health and disease

  1996cited by this paper
• FTIR microspectroscopic analysis of human osteonal bone

  1996cited by this paper
• Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

  1996cited by this paper
• Reduced concentrations of collagen cross-links are associated with reduced strength of bone.

  1995cited by this paper
• Collagens: molecular biology, diseases, and potentials for therapy.

  1995cited by this paper
• Abnormal bone mineralization after fluoride treatment in osteoporosis: A small‐angle x‐ray‐scattering study

  1994cited by this paper
• Simple measurement of femoral geometry predicts hip fracture: The study of osteoporotic fractures

  1993cited by this paper
• Biochemical changes in the collagen of human osteoporotic bone matrix.

  1993cited by this paper
• Long‐term fracture prediction by bone mineral assessed at different skeletal sites

  1993cited by this paper
• Cross-linking connectivity in bone collagen fibrils: the COOH-terminal locus of free aldehyde.

  1992cited by this paper
• Mineral crystals in calcified tissues: A comparative study by SAXS

  1992cited by this paper
• Post-translational modifications in the collagen of human osteoporotic femoral head.

  1992cited by this paper
• Type I procollagen: the gene-protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue.

  1989cited by this paper
• Effects of differences in mineralization on the mechanical properties of bone.

  1984cited by this paper
• Heritable diseases of collagen.

  1984cited by this paper

• PTH/PTHrP analogues as osteoanabolic treatment in patients with osteoporosis.

  2025cites this paper
• Fourier Transform Infrared Imaging of Bone.

  2025cites this paper
• Bone health and the masters runner

  2024cites this paper
• Bone hierarchical organization through the lens of materials science: Present opportunities and future challenges

  2024cites this paper
• Impact of anti-fracture medications on bone material and strength properties: a systematic review and meta-analysis

  2024cites this paper
• Effect of Teriparatide on Bone Mineral Density and Bone Markers in Real-Life: Argentine Experience

  2023cites this paper
• Bone intrinsic material and compositional properties in postmenopausal women diagnosed with long-term Type-1 diabetes.

  2023cites this paper
• Cortical bone material / compositional properties in growing children and young adults aged 1.5-23 years, as a function of gender, age, metabolic activity, and growth spurt.

  2022cites this paper
• Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR‐pQCT

  2022cites this paper
• Влияние костно-анаболической терапии на параметры костного ремоделирования и плотность кости у гериатрических пациентов с остеопорозом и синдромом падений

  2022cites this paper
• Bone Health: Basic and Applied Bone Biology

  2022cites this paper
• Bone quality in an ovariectomized monkey animal model treated with two doses of teriparatide for either 18 months, or 12 months followed by withdrawal for 6 months.

  2022cites this paper
• Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling

  2021cites this paper
• Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.

  2021cites this paper
• Teriparatide

  2021cites this paper
• Anabolic Agents for Postmenopausal Osteoporosis: How Do You Choose?

  2021cites this paper
• Lessons from bone histomorphometry on the mechanisms of action of osteoporosis drugs

  2021cites this paper
• Effect of hormone replacement therapy on bone formation quality and mineralization regulation mechanisms in early postmenopausal women

  2021cites this paper
• Bone tissue material composition is compromised in premenopausal women with Type 2 diabetes.

  2020cites this paper
• Knochenqualität und Schwingungsspektroskopie bei Fragilitätsfrakturen

  2020cites this paper
• Combined effect of teriparatide and an anti-RANKL monoclonal antibody on bone defect regeneration in mice with glucocorticoid-induced osteoporosis.

  2020cites this paper
• Histomorphometric analysis of bone remodeling

  2020cites this paper
• Basic Aspects of Bone Mineralization

  2020cites this paper
• PTH and PTHrP Analogs: Treatment of Osteoporosis

  2020cites this paper
• No evidence for alteration in early secondary mineralization by either alendronate, teriparatide or combination of both in transiliac bone biopsy samples from postmenopausal osteoporotic patients

  2020cites this paper
• Reduced Bone Modeling and Unbalanced Bone Remodeling: Targets for Antiresorptive and Anabolic Therapy.

  2020cites this paper
• Impact microindentation measurements correlate with cortical bone material properties measured by Fourier transform infrared imaging in humans.

  2020cites this paper
• Osteoporosis Therapeutics 2020.

  2020cites this paper
• Effects of teriparatide on bone in autochthonous transgenic model mice for diabetes mellitus (Akita mice)

  2019cites this paper
• PTH as An Anabolic Agent

  2019cites this paper
• Fourier Transform Infrared Imaging of Bone.

  2019cites this paper
• Reply to: Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials

  2019cites this paper
• Change in Bone Density and Reduction in Fracture Risk: A Meta‐Regression of Published Trials

  2019cites this paper
• Organic matrix quality discriminates between age- and BMD-matched fracturing versus non-fracturing post-menopausal women: A pilot study.

  2019cites this paper
• [Osteoporosis and quality of bone].

  2019cites this paper
• Teriparatide Treatment Increases Mineral Content and Volume in Cortical and Trabecular Bone of Iliac Crest: A Comparison of Infrared Imaging With X‐Ray–Based Bone Assessment Techniques

  2018cites this paper
• Examining the influence of PTH(1-34) on tissue strength and composition.

  2018cites this paper
• Impact of vitamin C on teriparatide treatment in the improvement of bone mineral density, strength, and quality in vitamin C-deficient rats

  2018cites this paper
• Effects of single or combination therapy of teriparatide and anti-RANKL monoclonal antibody on bone defect regeneration in mice.

  2018cites this paper
• The Effects of Long‐term Administration of rhPTH(1‐84) in Hypoparathyroidism by Bone Histomorphometry

  2018influential citation
• Vibrational spectroscopic techniques to assess bone quality

  2017cites this paper
• Clinical Evaluation of Bone Strength and Fracture Risk

  2017cites this paper
• The effects of parathyroid hormone peptides on the peripheral skeleton of postmenopausal women. A systematic review.

  2017cites this paper
• Intermittent Ibandronate Maintains Bone Mass, Bone Structure, and Biomechanical Strength of Trabecular and Cortical Bone After Discontinuation of Parathyroid Hormone Treatment in Ovariectomized Rats

  2017cites this paper
• Reduced Bone Material Strength is Associated with Increased Risk and Severity of Osteoporotic Fractures. An Impact Microindentation Study

  2017cites this paper
• Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone‐Forming Trabecular Surfaces

  2017cites this paper
• Bone Biology and Effects of Pharmaceutical Intervention on Bone Quality

  2017cites this paper
• Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study

  2016cites this paper
• Effects of Drugs on Bone Quality

  2016cites this paper
• Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).

  2016cites this paper
• Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled Trial.

  2016cites this paper
• Differential Effects of Teriparatide and Zoledronic Acid on Bone Mineralization Density Distribution at 6 and 24 Months in the SHOTZ Study

  2016cites this paper
• Osteoporosetherapie und Knochenmineralisation // Therapy of Osteoporosis and Bone Mineralization

  2016cites this paper
• 13. Analysis of mineral composition in osteoporosis

  2016cites this paper
• Osteoporosetherapie und Knochenmineralisation

  2016cites this paper
• Combined treatment with minodronate and vitamin C increases bone mineral density and strength in vitamin C-deficient rats

  2016cites this paper
• Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice

  2016cites this paper
• Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively‐Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years

  2016cites this paper
• PTH(1‐84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization

  2016influential citation
• Teriparatide for osteoporosis: importance of the full course

  2016cites this paper
• Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation.

  2016cites this paper
• Identification of Pyridinoline Trivalent Collagen Cross-Links by Raman Microspectroscopy

  2015cites this paper
• A NALYTICAL S TUDY OF O STEOPOROSIS OF M AXILLA IN O VARIECTOMIZED R ATS

  2015cites this paper
• Bone Matrix Composition Following PTH Treatment is Not Dependent on Sclerostin Status

  2015cites this paper
• Emerging therapeutic concepts for muscle and bone preservation/building.

  2015cites this paper
• Modifications in Bone Matrix of Estrogen-Deficient Rats Treated with Intermittent PTH

  2015cites this paper
• Efectos de la Hormona Paratiroidea PTH (1-84) en la consolidación de las fracturas

  2015cites this paper
• Bone’s Material Constituents and their Contribution to Bone Strength in Health, Disease, and Treatment

  2015cites this paper
• Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties

  2014cites this paper
• Altered Bone Material Properties in HLA‐B27 Rats Include Reduced Mineral to Matrix Ratio and Altered Collagen Cross‐Links

  2014cites this paper
• Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy

  2014cites this paper
• Commentary on Sclerostin Deficiency Is Linked to Altered Bone Composition

  2014cites this paper
• Studying Variations in Bone Composition at Nano-Scale Resolution: A Preliminary Report

  2014cites this paper
• Pediatric reference Raman data for material characteristics of iliac trabecular bone.

  2014cites this paper
• Fourier Transform Infrared Spectroscopic Characterization of Mineralizing Type I Collagen Enzymatic Trivalent Cross-Links

  2014cites this paper
• Strontium does not affect the intrinsic bone quality at tissue and BSU levels in iliac samples from Macaca fascicularis monkeys.

  2014cites this paper
• Changes in the Degree of Mineralization with Osteoporosis and its Treatment

  2014cites this paper
• Vibrational Spectroscopic Imaging for the Evaluation of Matrix and Mineral Chemistry

  2014cites this paper
• [Osteoanabolics and the forthcoming drugs for the treatment of osteoporosis].

  2014cites this paper
• Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis.

  2014cites this paper
• Role of Platelets Rich Plasma in Management of Osteoporotic Fractures

  2014cites this paper
• Raman analysis of proteoglycans simultaneously in bone and cartilage

  2014cites this paper
• Vibrational Spectroscopic Analysis of Hard Tissues

  2014cites this paper
• Pharmacokinetics, Tissue Distribution and Excretion of Recombinant Human Parathyroid Hormone 1–84 in Animals

  2013cites this paper
• Bone mineralization: from tissue to crystal in normal and pathological contexts

  2013cites this paper
• Applicability of ToF-SIMS for monitoring compositional changes in bone in a long-term animal model

  2013cites this paper
• Российский экспертный совет по применению инновационного препарата анаболического действия Форстео ® (терипаратид) в лечении тяжелого остеопороза

  2013cites this paper
• Parathyroid Hormone: Anabolic Treatment of Osteoporosis

  2013cites this paper
• Sequential treatment with teriparatide and strontium ranelate in a postmenopausal woman with atypical femoral fractures after long-term bisphosphonate administration

  2013cites this paper
• Bisphosphonates and PTH for Preventing Fractures

  2012cites this paper
• Teriparatide

  2012cites this paper
• Bone material properties in premenopausal women with idiopathic osteoporosis

  2012cites this paper
• Fourier transform infrared imaging of bone.

  2012cites this paper
• Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces

  2012cites this paper
• Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis

  2012cites this paper
• A Systems Approach to Understanding Bone Cell Interactions in Health and Disease

  2012cites this paper
• Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone

  2012cites this paper
• Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis

  2012cites this paper
• The Contribution of the Extracellular Matrix to the Fracture Resistance of Bone

  2012cites this paper
• Teriparatide in Bisphosphonate-Resistant Osteoporosis: Microarchitectural Changes and Clinical Results After 6 and 18 months

  2011cites this paper